TrialJournal of the American College of Cardiology2017

Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes.

James L Januzzi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.